The Capecitabine Global Market Report 2024 by The Business Research Company provides market overview across 60+ geographies in the seven regions – Asia-Pacific, Western Europe, Eastern Europe, North America, South America, the Middle East, and Africa, encompassing 27 major global industries. The report presents a comprehensive analysis over a ten-year historic period (2010-2021) and extends its insights into a ten-year forecast period (2023-2033).
Learn More On The Capecitabine Market:
https://www.thebusinessresearchcompany.com/report/capecitabine-global-market-report
According to The Business Research Company’s Capecitabine Global Market Report 2024, The capecitabine market size has grown strongly in recent years. It will grow from $2.06 billion in 2023 to $2.25 billion in 2024 at a compound annual growth rate (CAGR) of 9.4%. The growth in the historic period can be attributed to chemotherapy advancements, convenience of oral administration, regulatory approvals, treatment accessibility, oncologist recommendations
The capecitabine market size is expected to see strong growth in the next few years. It will grow to $3.14 billion in 2028 at a compound annual growth rate (CAGR) of 8.7%. The growth in the forecast period can be attributed to expanded indications, research in combination therapies, healthcare infrastructure development, government initiatives, adoption in developing countries. Major trends in the forecast period include targeted therapy combinations, expanded use in adjuvant settings, biomarker-driven treatment, enhanced pharmacogenomics, telehealth monitoring.
The increasing incidence of cancer is expected to propel the growth of the capecitabine market going forward. Cancer is a broad category of illnesses that can develop in any organ or tissue in the body when aberrant cells proliferate uncontrollably, cross their usual boundaries, and either spread to other organs or invade neighboring body parts. Capecitabine is used as a chemotherapeutic medication in cancer treatment, where it is enzymatically converted into the antimetabolite fluorouracil in the tumor, inhibiting DNA synthesis and slowing tumor tissue growth. For instance, in 2021, according to the American Cancer Society, a US-based community-based, voluntary health organization, there were an estimated 1.9 million new cancer cases diagnosed and 608,570 cancer deaths in the United States in 2021, an increase from 1.8 million new cancer cases diagnosed and 606,520 cancer deaths reported in 2020. Therefore, the increasing incidence of cancer is driving the growth of the capecitabine market.
Get A Free Sample Of The Report (Includes Graphs And Tables):
https://www.thebusinessresearchcompany.com/sample.aspx?id=12240&type=smp
The capecitabine market covered in this report is segmented –
1) By Drug Type: Branded, Generic
2) By Drug Formulation: Tablet, Capsules
3) By Distribution Channel: Hospital Pharmacy, Online Pharmacy, Retail Pharmacy
4) By Application: Colon Cancer, Rectal Cancer, Breast Cancer, Gastric Cancer, Other Applications
5) By End-Users: Hospitals, Homecare, Specialty Centers, Other End-Users
Product innovations are a key trend gaining popularity in the behavioral rehabilitation market. Major companies in the capecitabine market are focused on developing generic tablets to drive their revenues in the market. For instance, in February 2021, Dr. Reddy’s Laboratories, an India-based pharmaceutical company, launched Capecitabine tablets, a generic version of Xeloda, in the U.S. market. The therapeutic equivalent drug, approved by the U.S. Food and Drug Administration, is used in cancer treatment. The tablets are available in 150 mg and 500 mg strengths, in bottle counts of 60 and 120, respectively.
The capecitabine market report table of contents includes:
1. Executive Summary
2. Capecitabine Market Characteristics
3. Capecitabine Market Trends And Strategies
4. Capecitabine Market – Macro Economic Scenario
5. Global Capecitabine Market Size and Growth
.
.
.
26. South America Capecitabine Market
27. Brazil Capecitabine Market
28. Middle East Capecitabine Market
29. Africa Capecitabine Market
30. Capecitabine Market Competitive Landscape And Company Profiles
Top Major Players:
- Pfizer Inc
- Merck & Co. Inc
- Bayer AG
- Novartis AG
- Sanofi S.A
Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: [email protected]
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
